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BACKGROUND:  In  inflammatory  bowel  disease  (IBD),
cytokine  levels  (such  as  interleukin-1  (IL-1))  are
elevated. We have shown previously that IL-1 activates
phospholipid signaling pathways in intestinal epithe-
lial cells (IEC), leading to increased ceramide levels.
Aim: To determine whether ceramide induces apopto-
sis in IEC.
Methods: Apoptosis was evaluated by annexin-V bind-
ing or Hoechst nuclear staining. Levels of bcl-2, bcl-x,
bax,  p53  and  p21  were  determined  by  Western
blotting,  and  cell cycle  analysis  was  determined  by
flow cytometry.
Results:  IL-1  increased  ceramide  accumulation  in  a
time-dependent  and  concentration-dependent  man-
ner with a peak response at 4 h, with [IL-1] = 30 ng/ml.
Neither IL-1 nor ceramide induced apoptosis in IEC,
but they increased bcl-2 levels and decreased bax and
p21 levels without affecting bcl-x and p53 levels. They
also  caused  a  slight  but  significant  increase  in  the
G2/M phase. These data suggest a role for ceramide in
IBD  and  suggest  a  possible  mechanism  for  the
enhanced tumorigenic activity in IBD patients.
Key  words:  Epithelial  cells,  IL-1,  bcl-2,  bcl-x,  bax,  IBD,
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Introduction
Programmed cell death, apoptosis, plays a pivotal role
in the development and maintenance of homeostasis
within all multicellular organisms.1 Apoptosis can be
initiated by a variety of stimuli depending on the cell
type and on the subcellular component targeted by
each type of stimulant.
The sphingomyelin (SM) signal transduction path-
way has been shown to mediate apoptosis through
several  cell  surface  receptors  and  environmental
stresses.2,3The SM pathway is a ubiquitous signaling
system  in  which  ceramide  plays  a  central  role.
Ceramide has been implicated in a variety of cellular
processes from  cell  growth  and  differentiation  and
gene transcription to cell  death.4,5 Many receptors,
such as interleukin-1 (IL-1) and tumor necrosis factor-
a (TNF-a),  transduce  their  signal  via  the  SM  path-
way.4,6 In inflammatory bowel disease (IBD), which
includes  ulcerative  colitis  and  Crohn’s  disease,  the
levels of the cytokine IL-1 levels have been shown to
be  significantly  increased  due  to  the  infiltration  of
inflammatory  cells  into  the  intestinal  mucosa.  We
have  recently  shown  that  IL-1  causes  significant
accumulation in ceramide levels in intestinal epithe-
lial  cells  and  that  both  ceramide and  IL-1  increase
prostaglandin E2 (PGE2) production through inducing
cyclooxygenase-2 (COX-2)  synthesis,6,7 a major reg-
ulator  of  chloride  secretion. This  increase  in  PGE2
levels contributes significantly to the rise in chloride
and water secretion observed in IBD patients.
Colorectal cancer represents the major cause for
increased morbidity and mortality by malignant dis-
ease in  inflammatory  bowel  disease.8 Alterations in
the  level  of  expression  of  many  proto-oncogenes,
such  as  c-yes,  c-fos  and  c-abl,  or  expression  of
aberrant  gene  productions  have  been  observed  in
tumors  and  pre-cancerous  conditions.9 Specifically,
however, c-yes-enhanced expression in IBD patients
with tumors suggests the importance of this gene in
the development of colon cancer in IBD.9 Increased
tumor formation could be attributed to the increased
resistance of intestinal cells to apoptosis. Studies in rat
intestinal  epithelial  cells  have  shown  that  over-
expression of COX-2 leads to phenotypic changes in
these  cells  that  would  enhance  their  tumorigenic
potential. The cells  were resistant to apoptosis and
had elevated bcl-2 protein expression, both of which
were  reversed when  the  cells were  treated with  a
COX-2 inhibitor.10
Although  the  capacity  to  carry  out  apoptosis
appears to be inherent to all cells, the susceptibility to
apoptosis  varies  markedly  and  is  influenced  by
external and cell-autonomous events. The bcl-2 family
of proteins constitutes a critical intracellular check-
point of apoptosis within a distal common cell death
pathway.  Over-expression  of  bcl-2  prolonged  cell
survival  of  interleukin-3-dependent  pro-B-cell  lines
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G0.11 bcl-2  was  also  capable  of  protecting T  cells
against  a  variety  of  apoptotic  signals,  including
glucocorticoids, g-irradiation and phorbal esters.12,13
Over-expression of bax protein, on the contrary, leads
to accelerated apoptotic death in response to a death
signal, giving bax its designation as a death agonist.
The ratio of bcl-2 to bax is important in determining
susceptibility to apoptosis.14
In the present study, the effect of elevating ceramide
levels,  either  through  IL-1  receptors  or  by  the
exogenous addition of membrane-permeable synthetic
ceramide, on apoptosis in intestinal epithelial cells was
assessed and their effect on the levels on regulators of
apoptotic pathway and on cell cycle phases studied.
We present evidence that supports the hypothesis that
chronic inflammation of the mucosa in the absence of
apoptosis may explain the increased propensity of IBD
patients to colorectal cancers.
Materials and methods
Materials
Human recombinant IL-1a was a generous gift from
Immunex  (Seattle,  WA,  USA).  The  ECL  protein
detection kit and PVDF membrane were from Amer-
sham  (Amersham,  Bucks,  UK).  Fetal  bovine  serum
(FBS)  and  bovine  serum  albumin,  penicillin  and
streptomycin,  Dulbecco’s  Modified  Eagle’s  Medium
(DMEM), F-12 medium, pyruvate, non-essential amino
acids,  goat  serum  and  Earl’s  balanced  salt  solution
were from Gibco Laboratories (Paisley, UK). Acryla-
mide, N9,N9-bis-methylene-acrylamide, sodium dode-
cyl sulfate (SDS), glycine, tris, glycerol, 2-b-mercapto-
ethanol,  ammonium  persulfate,  N,N,N’,N’-tetra-
methylethylenediamine (TEMED), chloroform, ethyle-
nediamine  tetraacetic  acid,  ethylene  glycol-bis(b-
aminoethylether)-N,N,N’,N’-tetraacetic  acid  (EGTA),
methanol,  acetic  acid,  isopropanol,  dithiothreitol,
imidazole, LiCl, and camptothecine were from Sigma
(St Louis, MO, USA). Annexin-V was from Boehringer
Mannheim  (Mannheim,  Germany),  and  Hoechst
nuclear stain was from Molecular Probes (Portland,
OR, USA). Mouse antisera to p53, bcl-2, bcl-x and bax
were  purchased  from  Santa  Cruz  Biotechnology
(Santa  Cruz,  CA,  USA).  Mouse  antiserum  to  p21
(WAF1)  were  obtained  from  Oncogene  Research
Products  (Calbiochem,  San  Diego,  CA,  USA),  and
mouse  antibodies  to  poly(adenosine  diphosphate-
ribose)  polymerase  (PARP)  were  obtained  from
Enzyme  Systems  products  (Livermore,  CA,  USA).
Membrane-permeable  C2-ceramide  was  obtained
from  BioMol  (Plymouth  Meeting,  PA,  USA).  COX-2
inhibitor  L-745,337  (5-methanesulfonamide-
6-(2,4-difluorothiophenyl)-1-indanone),  was  a  gener-
ous gift from the Merck Frosst Center for Therapeutic
Research, Quebec, Canada.
Cell culture
Murine  small  intestinal  epithelial  cells  (IEC),  line
Mode-K,15 were  obtained  from  Dr  P.B.  Ernst  (Uni-
versity of Texas, Medical Branch, Galveston, TX, USA).
Mode-K  cells  were  maintained  in  DMEM  (low  glu-
cose) containing 10% FBS, 10 mM sodium pyruvate,
and  non-essential  amino  acids.  T-84  cells,  human
colonic cell line, were grown in DMEM/F-12 medium
supplemented  with  10%  FBS.  Cell  viability  was
measured using the trypan blue exclusion assay. An
increase in trypan blue positive cells could represent
increased  cellular  necrosis  or  late  changes  in  cell
permeability secondary to apoptosis.
Cells were trypsinized, centrifuged at 200 ´ g, and
washed in phosphate-buffered saline (PBS) twice. The
cells were then resuspended in PBS : 2x electrophore-
sis  sample  buffer,  ratio  1  :  1.  The  sample  buffer
consisted of 0.25M Tris–HCl (pH 6.8), 4% w/v SDS,
20% v/v glycerol and 0.1% bromophenol blue. Samples
were then boiled for 5min and stored at –80°C.
Measurement of ceramide levels
Lipids  were  extracted  from  cells  according  to  the
method of Bligh and Dyer.16 In brief, cell suspensions
were washed with PBS and the organic and aqueous
phases  were  separated  by  chloroform  and  water.
Ceramide levels were measured in the dried samples
using  a  modified  diacylglycerol  kinase  assay.17,18
Samples  were  solubilized  in  octyl-b-D-glucoside/dio-
leoyl  phosphatidylglycerol  micellar  solution
(7.5%/25 mM). To the lipid micelles, diglycerol kinase
and [g32P]adenosine triphosphate were added. Sam-
ples were then extracted and lipids were spotted on a
silica gel thin-layer chromatography plate. Plates were
developed with chloroform/acetone/methanol/acetic
acid/water  (50  :  20  :  15  :  10  :  5),  air  dried  and
subjected to autoradiography. The radioactive spots
corresponding to ceramide phosphate were scraped
into scintillation vials and the 32P activity counted in
a scintillation counter. Ceramide levels were normal-
ized to lipid phosphate. To measure lipid phosphate,
samples were oxidized with 150ml of 70% perchloric
acid at 180°C for 1h. Phosphate levels were measured
by the addition of ammonium molybdate and ascorbic
acid, and the absorbance read at 820nm.
Polyacrylamide gel electrophoresis and
Western blot analysis
Approximately 30mg of proteins obtained from cell
homogenates  from  various  treatments  were  loaded
onto  a  12%  SDS-polyacrylamide  gel,  subjected  to
electrophoresis,  blotted  onto  nitrocellulose  mem-
brane, and blocked in 5% non-fat milk containing 0.1%
Tween 20 in Tris-buffered saline for 1.5h. The blots
were incubated with the appropriate antibody at 4°C
in  1%  tris-buffered  saline  (TWEEN),  washed  and
reacted  with  horseradish  peroxidase-conjugated
F.R. Homaidan et al.
40 Mediators of Inflammation · Vol 11 · 2002secondary antibody. The protein bands were detected
with chemoluminescence utilizing the ECL detection
method and were quantified using ImageQuant soft-
ware and the Molecular Dynamics Storm 860 System
(Molecular Dynamics, Sunnyvale, CA, USA).
Apoptosis studies
IEC apoptosis was induced with various agents and
assessed by annexin-V binding using flow cytometry
or  by  Hoechst  nuclear  staining  using  fluorescence
microscopy. Apoptosis was induced by either one of
the following conditions.
1. Cells  were  exposed  to  either  ultraviolet  (UV)
50–60mJ/cm2 using a F5–10 T12 lamp (Westing-
house sunlamp  tube  (Lighting  Supplies,  Canton,
OH,  USA);  emission,  313nm)  or  to  g-irradiation
energy  at  527  rad/min  using  137Cs  as  a  source.
Both treatments have been shown to cause DNA
damage  and  to  mediate  radiation-induced  cell
apoptosis through the p53-dependent pathway.19
2. Cells  were  treated  with  1mM  camptothecin  for
24h  or  with  1 mM  H2O2 for  2h  as  positive
controls.  Camptothecin  is  an  anti-cancer  agent,
which inhibits DNA topo-isomerase I activity and
causes  DNA  double-strand  breaks  during  DNA
replication  to  induce  S-phase-dependent apopto-
sis,20 while  H2O2 induces  apoptosis  possibly
through activation of p53.21
The ability of IL-1 or ceramide to induce apoptosis in
Mode-K cells was assessed by treating the cells with
30ng/ml  of  IL-1  or  with  30mM  ceramide,  or  their
combination, for periods ranging from 2 to 24h.
For annexin V binding, 106 cells were washed in
PBS, pelleted at 200 ´ g for 5min, and then incubated
with FITC-conjugated Annexin-V in the presence of
1 mM  CaCl2.  Nuclei  of necrotic cells  were counter
stained  with  propidium  iodide  (PI)  (50mg/ml)  for
10min at room temperature, and cells were screened
by flow cytometry using Cell Quest software (approx-
imately 10,000 events). Apoptosis was estimated by
the relative amount of FITC-positive/PI-negative cell
populations. For Hoechst staining, cells were cultured
on  coverslips  to  around  80%  confluent. After  the
different treatments, cells were washed three times
with PBS for 10min and then incubated with Hoechst
stain #33342 (2mg/ml) for 20min, washed again in
PBS three times for 10min and fixed in formaldehyde
(4%), and observed under a fluorescence microscope.
Apoptotic  cells  were  recognized  by  the  typical
appearance of condensed chromatin in the nucleus
and apoptotic bodies.
Cell cycle analysis
Cells  were  harvested at  pre-determined time-points
after treatment, washed twice with cold PBS and fixed
in methanol (–20°C). Subsequently, cells were rinsed
with  PBS,  treated  with  Tris–HCl  buffer  (pH  7.4)
containing  1%  RNase  and  stained  with  PI  (final
concentration, 50mg/ml). Cells were centrifuged and
resuspended in 4% formaldehyde. The distribution of
different  DNA  contents  was  determined  using  a
FACScan flow cytometer (Becton Dickinson, San Jose,
CA, USA). In each sample, 10,000 ungated events were
acquired. Analysis of cell cycle distribution (including
apoptosis) was performed (Becton Dickinson).
Statistical analyses were performed with Student’s
t-tests for paired and unpaired data. Unless specified,
all results are presented as the mean ±standard error.
IL-1 is used throughout the paper to denote IL-1a.
Results
IL-1 increases ceramide levels in IEC
IL-1  has  been  shown  to  play  a  role  in  stimulating
sphingomyelin  breakdown.  IEC  were  treated  with
different  concentrations  of  IL-1  for  various  time
periods and the levels of ceramide measured. Basal
ceramide levels in Mode-K and T-84 cells were 2.6 ±
0.8 and 3.0 ± 0.1pmol/nmol  of phosphate, respec-
tively. These levels were increased significantly with
treatment  of  the  cells  with  [IL-1]  =  30ng/ml,  and
peaked in increase at 4 and 1h for Mode-K cells and
T-84  cells,  respectively  (Table  1).  The  maximum
increase in ceramide accumulation was similar for the
two cell lines. However, maximum levels of ceramide
were  reached  at  different  rates.  Ceramide  increase
was also dependent on the concentration of IL-1 used.
The  maximum  increase  in  ceramide  levels  was
reached at [IL-1] = 10–30ng/ml for both cell lines.
The effect of ceramide and IL-1 on IEC
apoptosis
Ceramide has been directly linked to the induction of
cytokine-mediated apoptosis.22 To test whether IL-1
IL-1 increases ceramide without inducing apoptosis
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Table 1. Effect of interleukin-1 (IL-1) on ceramide production
in intestinal epithelial cells (IEC)
a
Time (h) Ceramide levels (pmol/nmol)
Mode-K cells (n = 6) T-84 cells (n = 3)
0 2.6 ± 0.8 3.0 ± 0.1
1 N.D. 10.4 ± 0.6*
2 6.7 ± 1.2* 9.2 ± 1.0*
4 10.4 ± 1.3* 7.7 ± 0.5*
6 6.5 ± 1.2* 3.2 ± 0.04
12 6.3 ± 1.3* 3.0 ± 0.15
Data presented as mean ± standard error.
a Ceramide levels in IEC treated with IL-1 (30ng/ml) for different time
periods.
*p < 0.05, p value represents the comparison of the effect of IL-1b on
ceramide production as compared with untreated cells.causes  apoptosis,  IEC  were  treated  with  IL-1
(10–30ng/ml), with ceramide (10–30mM), or with a
combination of  both ceramide and IL-1  at different
concentrations. In Mode-K cells, IL-1 did not increase
the  number  of  apoptotic  cells  measured  at  24h;
neither did ceramide or their combination in Mode-K
cells (Fig. 1). Similarly, no increase in apoptosis was
observed  in T-84  cells  as  assessed  by  trypan  blue
exclusion assay (Table 2).
In contrast, apoptosis was induced by treatment of
the IEC with hydrogen peroxide, exposure to g-irra-
diation  or  UV-irradiation  (to  test  whether  the
p53-dependent  apoptotic  pathway  is  functional  in
these  cells),  or  camptothecin  (an  example  is  illus-
trated  in  Fig.  2).  These  treatments  resulted  in
increased  apoptosis  as  measured  by  annexin  FITC
fluorescence  using  flow  cytometry  or  by  Hoechst
staining  using  fluorescence  microscopy.  This  indi-
cates  that  IL-1  and/or  ceramide  treatment  did  not
induce  apoptosis  in  IEC,  although  the  cells  are
capable of undergoing apoptosis as observed by other
test agents or treatments.
We  have  reported recently  that IL-1  induces  the
expression  of  COX-2  in  IEC,6 through  ceramide.
Increased  COX-2  levels  have  been  associated  with
inhibition of apoptosis through increasing bcl-2 pro-
tein expression.10 Pre-treatment of Mode-K cells with
the  COX-2  inhibitor  (500nM)  L-745,337  and  then
treatment  with  ceramide  resulted  in  a  significant
increase  in  apoptosis  as  assessed  by  trypan  blue
exclusion assay (Table 3), which is in accordance with
what  has been  observed  in  rat  intestinal  epithelial
cells.10
The effect of ceramide and IL-1 on apoptosis
regulating proteins
We  examined  the  level  of  expression  of  the  major
cellular regulators of apoptosis that include bcl-2, bcl-
x and bax by Western blot analysis. In control Mode-K
cells, there was constitutive expression of all  three
proteins (Fig.  3). The addition of  IL-1 resulted in  a
sharp decrease in bax expression 2h post treatment,
was  significantly  decreased 6h  after  treatment and
was completely abolished by 24h (Fig. 3A). Ceramide
treatment as well as a combination of ceramide and IL-
1 caused an effect similar to that of IL-1 alone.
In contrast to bax downregulation, bcl-2 expression
was significantly increased by treatment of the cells
with  IL-1  and/or  ceramide  (Fig.  3),  while  bcl-x
expression was not modified (data not shown). These
results  suggest  that  IL-1  exerts  its  effect  through
ceramide accumulation to decrease the levels of pro-
apoptotic factors and to increase anti-apoptotic pro-
teins, hence shifting from the apoptotic pathway to
increasing  the  production  of  eicosanoids  as  was
observed  earlier.7 Further  evidence  that  IL-1  or
ceramide treatment did not induce apoptosis in Mode-
K cells is that neither the level or the integrity of PARP
enzyme was changed (data not shown).
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FIG. 1. The effect of ceramide and IL-1, and their combina-
tion, on inducing apoptosis in Mode-K cells measured 24h
after  treatment  (n =  4).  Apoptosis  was  measured  using
Annexin-V-Flous kit  and  cells  wereanalyzed by  flow  cyto-
metry. IL-1 and/or ceramide did not increase the apoptotic
index in any of the treatments.
FIG. 2. Ceramide had no effect on apoptosis in Mode-K cells (C), although cells did undergo apoptosis when exposed to
ultraviolet rays (B) as compared with a time control (A).
Table 2. Effect of interleukin-1 treatment on T-84 cells
a
Time (h) % Dead cells
(mean ± standard error)
0 1.04 ± 0.00
1 0.79 ± 0.01
2 1.53 ± 0.01
4 1.65 ± 0.48
12 1.63 ± 0.93
24 1.89 ± 1.08
a T-84 cells were treated with interleukin-1 (30ng/ml) for
different time periods. Cell viability was measured using
the trypan blue exclusion assay.The effect of ceramide and IL-1 on p53 and p21
protein levels
The levels of p53 and p21 were examined in cells
treated with IL-1 or ceramide at different concentra-
tions and different time periods. None of the treat-
ments had any effect on p53 levels, as assessed by
Western blotting assays (Fig. 4). However, p21 levels
were  decreased  significantly  within  1h  after  treat-
ment with either IL-1 or ceramide and peaked at 4h,
then returned to basal levels after 24h.
The effect of ceramide and IL-1 on cell cycle
To  investigate  whether ceramide  and/or  IL-1  affect
cell proliferation, cell cycle analysis was performed by
measuring DNA content as described in ‘Materials and
methods’. No major modification of the distribution
of  the different cell cycle phases (pre-G0, G0/G1, S
and G2/M phases) was observed except for a moder-
ate increase in the percentage of cells in the G2/M
phase in IL-1 and/or ceramide-treated cells, resulting
in a decrease in the percentage of cells in the G0/G1
phases (Fig. 5).
Cell  cycle  analysis  was  also  employed  for  the
evaluation of apoptosis. The percentages of cells in
the pre-G0/G1 phase (representing,  at least in  part,
apoptotic cells) in control as well as in treated cells
were not different (3.25 ± 0.2% in control untreated
cells versus 4.95 ± 2.4 in 30ng/ml of IL-1-treated cells;
not significant). Thus, the induction of apoptosis by
these treatments was ruled out.
Discussion
IL-1,  a pro-inflammatory cytokine, is  produced and
secreted by inflammatory cells and other cell types in
response to a variety of stimuli. It is involved in many
inflammatory responses and  is a potent inducer of
arachidonic acid mobilization and its metabolism to
prostaglandins and other eicosanoids, a hallmark of
inflammatory  response.  Several  second  messengers
have  been  shown  to  mediate  the  effects  of  this
cytokine. In intestinal epithelial cells, we have shown
that IL-1 elicits its effects mainly through activating
phospholipid messengers. It increases phospholipase
A2 (PLA2) activity,23 and increases the expression of
PLA2-activating  protein  and  the  enzyme  COX-2.6,7
These effects lead to increased levels of PGE2 and to
a  subsequent  increase  in  Cl– secretion.24 Bioactive
lipids, generated in response to activation of various
lipases, serve as intracellular and extracellular media-
tors in cell signaling. They play important roles in a
variety of processes involving  cell–cell communica-
tion, inflammation, host-defense mechanisms, and in
ischemia reperfusion. Ceramide, which is generated
from  SM  by  the  action  of  the  ubiquitous  enzyme
sphingomyelinase  (SMase),  serves  as  an  important
IL-1 increases ceramide without inducing apoptosis
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Table 3. Percentage of apoptosis in Mode-K cells
Treatment % Dead cells
(mean ± standard error)
a
n
b
Control untreated cells 4.6 ± 0.1 6
L-745,337
c (500nM), 24h treatment 4.3 ± 0.1 4
Ceramide (30mM), 24h treatment 4.3 ± 0.5 6
L-745,337
c (500nM), pre-treatment for 1h + ceramide (30mM), 24h treatment 11.6 ± 1.4 4
H2O2 (1 mM), 2h treatment 41.0 ± 10.0 6
a Mode-K cell viability was measured using the trypan blue exclusion assay.
b Number of experiments.
c COX-2 inhibitor used, L-745,337 (5-methanesulfonamide-6-(2,4-difluorothiophenyl)-1-indanone) .
FIG. 3. A representative Western blot (n = 5) showing the
effect of IL-1 (30ng/ml) and ceramide (30mM) on the levels of
protein regulators of apoptosis. (A) Both IL-1 and ceramide
caused  a  sharp  decrease  in  bax  protein  levels  1h  after
treatment, and bax was abolished by 24h. (B) Both IL-1 and
ceramide  caused  an  increase  in  bcl-2  levels  4h  after
treatment.
FIG. 4. A representative Western blot (n = 4) showing: (A) the
lack  of  effect  of  IEC  treatment  by  IL-1  (30ng/ml)  and/or
ceramide on p53 levels, and (B) the decrease in p21 levels by
IL-1 and/or ceramide.pleiotropic signal transducer in apoptosis as well as in
cell proliferation and differentiation.4,5,25All sphingo-
lipids  contain  ceramide  as  the  basic  hydrophylic
component that is released by activated SMase. SMase
can be activated by a variety of extracellular signals
and stimulants including TNF-a, g-interferon, IL-1 and
ionizing radiation. The nature of ceramide-mediated
signaling  suggests  that  the  SM  pathway  may  link
downstream to a variety of effector systems. Evidence
suggest that ceramide play a role in signaling of both
the pro-inflammatory and apoptotic effects of TNF-
a.26 Ceramide also stimulates cytokine production in
some  cell  types,  suggesting  a  role  in  extracellular
signaling  via the  cytokine network.27 A connection
between cytokine signaling, inflammation and the SM
pathway have also been suggested4 by virtue of the
effects of ceramide on the induction of PGE2 produc-
tion. Ceramide has also been implicated in increasing
PLA2 activity  and  stimulating  the  transcription  of
cyclooxygenase in inflammation, leading to increased
production  of  PGE2.4,28 However,  we  have  shown
recently that ceramide increased the production of
PGE2 in  intestinal  epithelial  cells  through  inducing
COX-2 synthesis without any effect on PLA2 activity.6
The  generation  of  eicosanoids such  as PGE2 repre-
sents an important signaling system utilized by many
cytokine/growth factor receptors. Hence, it appears
that there is a cross-talk between receptor signaling
through activation of the SM pathway and eicosanoid
production.
Ceramide  has  also  been  implicated  in  cytokine-
mediated apoptosis.22,29 This was supported by the
finding  that  apoptosis  was  induced  by  exogenous
bacterial  SMase,  which  cleaves  SM  to  result  in
ceramide. In the present study, we show that neither
ceramide nor IL-1 increase IEC apoptosis. These data
suggest that ceramide does not activate the apoptotic
pathway, but rather feeds into the eicosanoid meta-
bolic pathway.  Similar  findings  have been reported
recently in human leukemic cells30 and in rat alveolar
cells.31 Exogenous ceramide failed to trigger apopto-
sis in human myelogenous leukemic cells30 although
TNF-a-induced apoptosis was blocked by a sphingo-
myelinase inhibitor. This indicates that ceramide was
necessary but not sufficient for TNF-a-induced apop-
tosis. Mallampalli et al. also observed that ceramide
resulting  from  TNF-a activation  of  SM  hydrolysis
might  activate the  mitogen-activated protein kinase
and nuclear factor (NF)-kB pathways without increas-
ing programmed cell death in alveolar type II epithe-
lial cells.31
In addition to the tightly  regulated pro-apoptotic
mechanisms,  mammalian  cells  also  operate  anti-
apoptotic mechanisms to constrain apoptosis. These
include the bcl-2 system,32–34 loss of p53 activity,35,36
activation of NF-kB,37,38 and activation of the 1,2-dia-
cylglycerol-protein  kinase  C  signaling  system.39,40
These anti-apoptopic systems and the pro-apoptotic
systems are both subject to regulation. While origi-
nally bcl-2-related proteins were reported to confer
anti-apoptotic protection, it was subsequently shown
that  some  members  of  this  family  serve  as  pro-
apoptotic factors.32,34 bcl-2  and bcl-x  are the main
members of this family that inhibit apoptosis, while
bax and bad are the two best known pro-apoptotic
factors.  Prolonged  cell  survival  with  resistance  to
apoptosis  can  be  a  primary  oncogenic  event.  Evi-
dence has emerged that a principal contribution from
the loss of p53 function is the elimination of a death
pathway.41,42 In  select  settings,  stimuli  that  induce
p53 result in the expression of bax.43 In the present
study, p53 levels as well as bcl-x were not affected by
treatment of the cells by IL-1 and/or ceramide, while
bax  levels  were  decreased  significantly  and  bcl-2
levels were increased, further supporting the finding
that  ceramide  does  not  lead  the  cells  into  the
apoptotic pathway. Furthermore, the increased pro-
liferation observed in treated intestinal epithelial cells
correlated with the decreased protein levels of the
cyclin-dependent kinase inhibitor p21 reported in this
study.
Recent studies have shown that induction of PGE2
and COX-2 levels inhibit apoptosis in IEC44 through
inducing bcl-2 expression but with no effect on bax
expression. This could explain the lack of apoptosis in
Mode-K cells since we have shown that ceramide and
IL-1  induce  COX-2  and/or  PLA2,  both  leading  to
increased levels of PGE2.6
These data suggest that while ceramide might still
initiate the upstream apoptotic pathway, it does not
commit  the  cell  to  the  death  process. The  bcl-2
protein family can still reverse the process at multiple
checkpoints  along  the  apoptotic-signaling  pathway.
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FIG. 5. Effects of IL-1 (30ng/ml) and ceramide (30mM) on the
cell cycle distribution of IEC after 24h of treatment. Histo-
gram-related nuclear DNA contents were measured by flow
cytometry as described in ‘Materials and methods’. The sum
of G0/G1 and S–G2/M phases is normalized to 100% (n = 3).Apoptosis plays a major role in the pathogenesis of
disease and its management. Improved understanding
of  mechanisms  of  pro-apoptosis  and  anti-apoptosis
and their coordinated function may yield opportun-
ities  for  pharmacological  interventions  in  human
disease with important potentials for clinical applica-
tions. The anti-apoptotic effects caused by  IL-1  and
ceramide suggest a role for them in IBD and propose
a possible mechanism for the enhanced tumorigenic
activity of intestinal epithelial cells in IBD patients.
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